UTHR

United Therapeutics Corp

United Therapeutics Corp is a leading biotechnology company that specializes in developing and commercializing innovative therapies for patients suffering from chronic and life-threatening diseases. With a primary focus on pulmonary arterial hypertension (PAH), a rare and progressive disease that affects the lungs and heart, the company has successfully developed several FDA-approved treatments, including Remodulin, Tyvaso, and Orenitram. In addition to its current portfolio, United Therapeutics Corp has a robust pipeline of potential therapies for PAH, cancer, and organ transplantation. The company is dedicated to improving patient outcomes through scientific innovation and collaboration with healthcare professionals, patient advocacy groups, and other stakeholders. Headquartered in Silver Spring, Maryland, United Therapeutics Corp operates globally, with a presence in the United States, Europe, and Asia.

Instrument specification for United Therapeutics Corp

Name
Minimum order value
Description
Maximum order value
Transaction Step
Type
Trading Hours
Contract size / 1 lot
Deposit required
Value of 1 pip
Financial leverage
Minimal step
Long swap (daily)
Short sale NO
Short swap (daily)
Distance SL and TP 0
3-day swap (date)

Start trading now with fast account opening.

Sign-up now to trade the most active markets

Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
Scroll to top